ARK Invest has pushed its holding past 150 million shares. Nearly 10% of Ginkgo is owned by two ARK Invest ETFs. Shares remain close to their public trading lows. ETF firm Ark Invest, run by Cathie ...
Ginkgo Bioworks (NYSE: DNA) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback